A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

ClinicalTrials.gov ID: NCT07431177

Public ClinicalTrials.gov record NCT07431177. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 5, 2026, 6:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase IIb Study to Assess the Efficacy and Safety of GIA632 in Adult Participants With Non-segmental Vitiligo Followed by an Extension Period

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optimal dose to be promoted into the confirmatory Phase 3 program.

Study identification

NCT ID: NCT07431177
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Novartis Pharmaceuticals; Industry
Enrollment: 210 participants

Conditions and interventions

Conditions

Non-segmental Vitiligo

Interventions

GIA632 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 99 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 8, 2026
Primary completion: Jun 5, 2028
Completion: Jan 27, 2030
Last update posted: Aug 18, 2026

2026 – 2030

United States locations

U.S. sites: 21
U.S. states: 12
U.S. cities: 21

Facility	City	State	ZIP	Site status
Cahaba Derm and skin hlth ctr 27	Birmingham	Alabama	35244	Recruiting
First OC Dermatology	Fountain Valley	California	92708	Recruiting
MedDerm Associates	San Diego	California	92103	Recruiting
Clinical Trials Research Institute	Thousand Oaks	California	91320	Recruiting
Encore Medical Research	Hollywood	Florida	33024	Recruiting
Mayo Clinic Jacksonville	Jacksonville	Florida	32224	Recruiting
Miami Derm and Laser Institute	Miami	Florida	33173	Recruiting
Global Clinical Professionals	St. Petersburg	Florida	33714	Recruiting
Dawes Fretzin Clinical Rea Group	Indianapolis	Indiana	46256	Recruiting
Hamzavi Dermatology	Fort Gratiot	Michigan	48059	Recruiting
Revival Research Institute	Troy	Michigan	48084	Recruiting
Skin Specialists PC	Omaha	Nebraska	68144	Recruiting
Las Vegas Dermatology	Las Vegas	Nevada	89144	Recruiting
Equity Medical	The Bronx	New York	10455	Recruiting
Oregon Medical Research Center	Portland	Oregon	97223	Recruiting
International Clinical Research Tennessee LCC	Murfreesboro	Tennessee	37130	Recruiting
Bellaire Dermatology Associates	Bellaire	Texas	77401	Recruiting
Center for Clinical Studies	Houston	Texas	77030	Recruiting
Austin Inst for Clinical Research	Pflugerville	Texas	78660	Recruiting
ACRC Trials	Plano	Texas	75024	Recruiting
Virginia Clinical Research	Norfolk	Virginia	23507	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07431177, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 18, 2026 · Synced Sep 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07431177 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →